Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate-Reference-Cited by-同舟云学术

Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate

Published:1999-03 Issue:3 Volume:82 Page:293-295
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Kimata Hajime

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference9 articles.

1. Diagnostic features of atopic dermatitis;Hanfin;Acta Derma Venereol,1980

2. Effect of hydrocortisone on spontaneous IgE and IgG4 production in atopic patients;Kimata;J Immunol,1995

3. Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis;Hiratsuka;J Allergy Clin Immunol,1966

4. Rebound phenomenon after withdrawal of steroid ointment in patients with atopic dermatitis;Matsunaga;Sougourinshou,1996

5. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2) Regulation of human IgE response;Yanagihara;Japan J Pharmacol,1993

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decrease of Hyaluronidase Activity and Suppression of Mouse CD4+ T Lymphocyte Activation by Tomato Juice Saponin Esculeoside B, and Its Sapogenol Esculeogenin B;Journal of Personalized Medicine;2022-04-05

2. Efficacy and safety of 0.0584% hydrocortisone aceponate topical spray and systemic oclacitinib combination therapy in dogs with atopic dermatitis: a randomized, double‐blinded, placebo‐controlled trial;Veterinary Dermatology;2020-11-13

3. Considerations in Weaning or Withdrawing Dupilumab Therapy—Nothing Is Forever;JAMA Dermatology;2020-02-01

4. Competitive Inhibition of Mammalian Hyaluronidase by Tomato Saponin, Esculeoside A;Natural Product Communications;2018-11

5. Remittive effect of Dupilumab in atopic dermatitis;Dermatologic Therapy;2018-09-25